Cannabis News for Florda
Tel Aviv, Dec. 12, 2017: Israel-Cannabis and Aura Medical have joined forces to bring FDA approved nebulizers to the burgeoning medical cannabis market. The... iCAN:Israel-Cannabis to bring FDA approved nebulizers to the medical cannabis market

Tel Aviv, Dec. 12, 2017: Israel-Cannabis and Aura Medical have joined forces to bring FDA approved nebulizers to the burgeoning medical cannabis market.

The Aura’s Portable Nebulizer is widely acclaimed and recommended by the nation’s top Pulmonologists and Respiratory Therapists for use in treating asthma and COPD and now will be used by millions more worldwide. The device will be marketed under the brand name “Nebican”.

Utilizing specially developed controlled dosages, the Nebican portable nebulizer is a perfect delivery system for medical cannabis. Nebican is the answer to medical practitioners and patients worldwide as demand turns towards medical cannabis to alleviate numerous ailments.

Designed with patented Vibrating Mesh Technology (VMT), Nebican is an innovative form of atomization that emits extremely thin and fog like vapor. Like air, the mist released from the inhaler can easily penetrate deep into the lungs. Pocket sized, it is portable, discreet, convenient and easy to use.

The_Nebican_Portable_Nebulizer

“We are proud to pair our unique delivery platform, that until now been used for prescription medications including Albuterol®, Pulmicort Respules®, DuoNeb® Intal and others, with targeted formulation from Ci Therapeutics”. Said Connie Lefkowitz, CEO of Aura Medical

Ci Therapeutics, (an iCAN & CannRX partnership) has significantly progressed on its validation of ican.sleep, an advanced cannaceutical to be delivered on the Nebican inhalation platform.

Nebican & ican.sleep are expected to launch in California in mid-2018 with the Canadian market to follow.

“This is a game changer, taking an advanced pulmonary FDA approved delivery platform and formulating a sleep product to deliver safe cannabis in a doseable and repeatable way,” said iCAN: Israel-Cannabis Founder and CEO, Saul Kaye.

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.